Douglas John Barry

Douglas John Barry

Direttore/Membro del Consiglio presso
Redwood Toxicology Laboratory, Inc.
56 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Douglas John Barry is currently Director at Redwood Toxicology Laboratory, Inc. and Secretary, Chief Legal Officer & Senior VP at Kiniksa Pharmaceuticals International Plc starting in 2025.
Former roles include Secretary & Director at Achillion Pharmaceuticals, Inc., Director at Alere Toxicology Services, Inc., Director at BBI Diagnostics Group 2 Plc from 2015 to 2017, Secretary, Chief Legal & Compliance Officer at Tango Therapeutics, Inc. from 2024 to 2025, Vice President-Corporate Law at Alexion Pharmaceuticals, Inc. from 2018 to 2020, and Associate General Counsel at Alere, Inc. from 2015 to 2018.
Education includes graduate degrees from Northwestern University School of Law and Virginia International University, and an undergraduate degree from Hobart & William Smith Colleges.

Posizioni attive di Douglas John Barry

SocietàPosizioneInizio
Direttore/Membro del Consiglio -

Precedenti posizioni note di Douglas John Barry

SocietàPosizioneFine
TANGO THERAPEUTICS, INC. Responsabile della Conformità 12/09/2025
ALERE INC Consigliere Generale 01/04/2018
Direttore/Membro del Consiglio 03/10/2017
ACHILLION PHARMACEUTICALS, INC. Direttore/Membro del Consiglio -
ALEXION PHARMACEUTICALS, INC. Direttore/Membro del Consiglio -
Vedi nel dettaglio l'esperienza di Douglas John Barry

Formazione di Douglas John Barry

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

63

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Health Services

Consumer Services

Health Technology

  1. Mercati
  2. Insiders
  3. Douglas John Barry
ULTIMI ORARI | -40%: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA